The highest prevalences of MUC6 expression were seen in carcinomas of the breast, adenocarcinomas of the stomach, esophagus, colorectum, and the pancreas, as well as in carcinomas of the endometrium and the ovary. Here, MUC6 is linked to breast carcinoma.